Granules India gets USFDA’s nod for hypertension generic Subject: Science and Tech Section: Health More about the news: Granules India received USFDA approval for its new generic drug, equivalent to Losartan Potassium and Hydrochlorothiazide Tablets.  It treats hypertension and stroke risk reduction, with an annual US market value of around $73 million.  This […]